Skip to main content

Key Attorneys Might Get $366 M in Boston Pelvic Mesh MDL

Key Attorneys Might Get $366 M in Boston Pelvic Mesh MDL

Key Attorneys Might Get $366 M in Boston Pelvic Mesh MDL

Introduction

In a pretrial order, U.S. District Court Judge Joseph Goodwin announced that attorneys representing thousands of plaintiffs in the pelvic mesh product liability cases against Boston Scientific might receive $366 million or 5% of the total recoveries in the cases.

Judge Goodwin wrote that the plaintiffs' attorneys were required to spend tens of millions of dollars over nine years while fighting for 104,000 patients. He stated, tens of thousands of cases have been resolved so far for about $7.25 billion and, these costs would continue to grow but are a small part of what the common benefit fund was formed to compensate. To calculate the costs petitioned for the 5% sum to be set aside for their colleagues whose work was beneficial to the plaintiffs, a committee of plaintiffs' attorneys is appointed.  

Pelvic mesh lawsuits, filed against Boston Scientific Corp., are consolidated before Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia as a part of multidistrict litigation (MDL No. 2326: In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation) for coordinated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!